41
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Optimizing knowledge of antiviral medications for prophylaxis and treatment of influenza during pregnancy

Pages 495-501 | Published online: 09 Jan 2014

References

  • Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR53(RR-6), 1–40 (2004).
  • Neuzil K, Reed G, Mitchel E, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am. J. Epidemiol.148, 1094–1102 (1998).
  • Schanzer DL, Langley JM, Tam TWS. Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J. Obstet. Gynaecol. Can.29, 622–629 (2007).
  • Schanzer DL, Langley JM, Tam TWS. Modelling the impact of influenza in Canada: a baseline for pandemic planning. Presented at: Second North American Congress of Epidemiology. Seattle, WA, USA, 21–24 June 2006.
  • Dodds L, McNeil SA, Fell DB et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ176(4), 463–468 (2007).
  • Parkins M, Fonseca K, Peets AD, Laupland KB, Shamseddin K, Gill MJ. A potentially preventable case of serious influenza infection in a pregnant patient. CMAJ177, 851–853 (2007).
  • Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso AJ et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet374, 2072–2079 (2009).
  • Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med.361, 680–689 (2009).
  • Campbell A, Rodin R, Kropp R et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ182(4), 349–355 (2010).
  • Oluyomi-Obi T, Avery L, Schneider C et al. Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 influenza A. J. Obstet. Gynaecol. Can.32(5), 443–447 (2010).
  • Centers for Disease Control and Prevention. Novel influenza A (H1N1) virus infections in three pregnant women – United States. MMWR Morb. Mortal. Wkly Rep.58(18), 497–500 (2009).
  • Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet374, 451–458 (2009).
  • Creanga AA, Johnson TF, Graitcer SB et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet. Gynecol.115(4), 717–726 (2010).
  • Centers for disease control and prevention. 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care – New York City, 2009. MMWR Morb. Mortal. Wkly Rep.59(11), 321–326 (2010).
  • Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N. Engl. J. Med.362(1), 27–35 (2010).
  • Hewagama S, Walker SP, Stuart RL et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin. Infect. Dis.50, 686–690 (2010).
  • Nichol KL, Lind A, Margolis KL et al. The effectiveness of vaccination against influenza in healthy, working adults. N. Engl. J. Med.333, 889–893 (1995).
  • Public Health Agency of Canada. National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 2008–2009 season. CCDR34(ACS-3), 1–46 (2008).
  • France EK, Smith-Ray R, McClure D et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch. Pediatr. Adolesc. Med.160, 1277–1283 (2006).
  • Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med.359, 1555–1564 (2008).
  • Public Health Agency of Canada. National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 2007–2008 season. CCDR33(ACS-7), 1–38 (2007).
  • Gonik B, Jones T, Contreras D, Fasano N, Roberts C. The obstetrician-gynecologist’s role in vaccine-preventable diseases and immunization. Obstet. Gynecol.96, 81–84 (2000).
  • Centers for Disease Control and Prevention. Influenza vaccination in pregnancy: practices among obstetrician-gynecologists – United States, 2003–04 influenza season. MMWR Morb. Mortal. Wkly Rep.54(41), 1050–1052 (2005).
  • Yudin MH, Salaripour M, Sgro MD. Pregnant women’s knowledge of influenza and the use and safety of the influenza vaccine during pregnancy. J. Obstet. Gynaecol. Can.31(2), 120–125 (2009).
  • Fiore AE, Shay DK, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.57, 1–60 (2008).
  • Centers for Disease Control and Prevention. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women – 10 states, 2009–10 influenza season. MMWR Morb. Mortal. Wkly Rep.59(47), 1541–1545 (2010).
  • Munoz FM, Greisinger AJ, Wehmanen OA et al. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol.192, 1098–1106 (2005).
  • Black SB, Shinefeld HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am. J. Perinatol.16, 283–286 (1999).
  • Englund JA. Maternal immunization with inactivated influenza vaccine: rationale and experience. Vaccine21, 3460–3464 (2003).
  • Englund JA, Mbawuike IN, Hammil H, Holleman MC, Baxter BC, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J. Infect. Dis.168, 647–656 (1993).
  • Deinard AS, Ogburn P Jr. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am. J. Obstet. Gynecol.140, 240–245 (1981).
  • Bartman BA, Weiss KB. Women’s primary care in the United States: a study of practice variation among physician specialties. J. Women’s Health2, 261–268 (1993).
  • Tong A, Biringer A, Ofner-Agostini M, Upshur R, McGeer A. A cross-sectional study of maternity care providers’ and women’s knowledge, attitudes, and behaviours towards influenza vaccination during pregnancy. J. Obstet. Gynaecol. Can.30(5), 404–410 (2008).
  • Broughton DE, Beigi RH, Switzer GE, Raker CA, Anderson BL. Obstetric health care workers’ attitudes and beliefs regarding influenza vaccination in pregnancy. Obstet. Gynecol.114, 981–987 (2009).
  • Yudin MH, Salaripour M, Sgro MD. Impact of patient education on knowledge of influenza and vaccine recommendations among pregnant women. J. Obstet. Gynaecol. Can.32(3), 232–237 (2010).
  • Burpo RH. Antiviral agents in women’s health: pharmacotherapeutics of treating influenza and herpes. J. Midwifery Womens Health47, 182–189 (2002).
  • Jefferson TO, Demicheli V, Di Pietrantonj C et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst. Rev.3, CD001265 (2006).
  • Matheson NJ, Harnden A, Perera R et al. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst. Rev.1, CD002744 (2007).
  • Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ181(1–2), 55–58 (2009).
  • Freund B, Gravenstein S, Elliott M et al. Zanamivir: a review of clinical safety. Drug Saf.21, 267–281 (1999).
  • Greer LG, Sheffield JS, Rogers VL, Roberts SW, McIntire DD, Wendel GD. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet. Gynecol.115(4), 711–716 (2010).
  • Wentges-van Holthe N, van Eijkeren M, van der Laan JW. Oseltamivir and breastfeeding. Int. J. Infect. Dis.12, 451 (2008).
  • Bozzo P, Djokanovic N, Koren G. H1N1 influenza in pregnancy: risks, vaccines, and antivirals. J. Obstet. Gynaecol. Can.31(12), 1172–1175 (2009).
  • Gaglia MA, Cook RL, Kraemer KL, Rothberg MB. Patient knowledge and attitudes about antiviral medication and vaccination for influenza in an internal medicine clinic. Clin. Infect. Dis.45, 1182–1188 (2007).
  • Centers for Disease Control and Prevention. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among medicare beneficiaries aged ≥65 years – United States, 1991–2002. MMWR Morb. Mortal. Wkly Rep.53, 1012–1015 (2004).
  • Belongia EA, Naimi TS, Gale CM, Besser RE. Antibiotic use and upper respiratory infections : a survey of knowledge, attitudes, and experience in Wisconsin and Minnesota. Prev. Med.34, 346–352 (2002).
  • Cummings KC, Rosenberg J, Vugia DJ. Beliefs about appropriate antibacterial therapy, California. Emerg. Infect. Dis.11, 1138–1141 (2005).
  • Wilson AA, Crane LA, Barrett PH, Gonzales R. Public beliefs and use of antibiotics for acute respiratory illness. J. Gen. Intern. Med.14, 658–662 (1999).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.